# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-000208
Filing Date
2025-03-24
Accepted
2025-03-24 08:30:38
Documents
69
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 2728933
2 |  | ex23-1.htm | EX-23.1 | 3357
3 |  | ex31-1.htm | EX-31.1 | 12275
4 |  | ex31-2.htm | EX-31.2 | 12189
5 |  | ex32-1.htm | EX-32.1 | 7040
6 |  | ex32-2.htm | EX-32.2 | 8089
7 |  | form10-k_001.jpg | GRAPHIC | 20468
8 |  | form10-k_002.jpg | GRAPHIC | 90281
9 |  | form10-k_003.jpg | GRAPHIC | 87277
10 |  | form10-k_004.jpg | GRAPHIC | 93606
| Complete submission text file | 0001641172-25-000208.txt |  | 9885958

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL SCHEMA FILE | lixt-20241231.xsd | EX-101.SCH | 51105
12 | XBRL CALCULATION FILE | lixt-20241231_cal.xml | EX-101.CAL | 43043
13 | XBRL DEFINITION FILE | lixt-20241231_def.xml | EX-101.DEF | 287888
14 | XBRL LABEL FILE | lixt-20241231_lab.xml | EX-101.LAB | 477079
15 | XBRL PRESENTATION FILE | lixt-20241231_pre.xml | EX-101.PRE | 383576
71 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 1251851

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39717 | Film No.: 25762332
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)